Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer
for Anatomic Stage IV Breast Cancer AJCC v8
Drug: Tremelimumab
Sites in Winston-Salem, Clemmons +21 more locations
Sponsor: National Cancer Institute (NCI)
Sex: All·Age: 18+
Code: NCT03606967·Phase 2·Recruiting·Listed Jul 2018